WuXi XDC announced the signing of a Memorandum of Understanding (MoU) for a comprehensive collaboration in drug-linker technology and CRDMO services spanning from discovery to commercialization. Dr. Jimmy Li, CEO of WuXi XDC, commented...
Suzhou Ribo Life Science Co., Ltd. and Ribocure AB collaborate with Boehringer Ingelheim to discover innovative treatments for steatohepatitis caused by nonalcoholic or metabolic dysfunction. The collaboration combines Ribo's expertise in the...
Dr. Reddy's purchased Amyris' MenoLabs business, a prominent women's health and dietary supplement branded portfolio, for $3 million in a Chapter 11 bankruptcy action in the United States Bankruptcy Court for the District of Delaware. Dr. Reddy’s...
Alembic Pharmaceuticals Limited has gained FDA approval for eight of its Abbreviated New Drug Applications (ANDA) in Q3FY24. The company has received five final approvals that includes selexipag tablets, 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1,400...
Glenmark Pharmaceuticals Ltd. (Glenmark), a worldwide pharmaceutical business focused on research, has introduced a biosimilar of the popular anti-diabetic medicine liraglutide in India for the first time. Following permission from the medicine...
CareCloud, Inc., a national leader in health care technology solutions for physician practices and health systems, announced a strategic partnership with Kovo HealthTech Corporation, a pioneer in healthcare technology and Billing-as-a-Service...
Voyager Therapeutics, Inc., a biotechnology company focused on the advancement of neurogenetic medicines, announced a strategic collaboration and capsid license agreement with Novartis Pharma AG, a subsidiary of Novartis AG (NYSE: NVS), to advance...
BDR Pharmaceuticals announced the launch of Enzalutamide oral solution for the treatment of prostate cancer, claiming to be the first company in the world to do so. The company has introduced the Enzalutamide oral solution as BDENZA, in 32 mg/ml...
Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the...
Roche announced the signing of a definitive agreement to buy certain components of the LumiraDx group relating to the revolutionary Point of Care technology developed by LumiraDx. The purchased firms will be fully integrated into Roche Diagnostics...
, CDSCO.jpg)
